EXHIBIT 9
SERIES B PREEMPTIVE RIGHTS AGREEMENT
THIS SERIES B PREEMPTIVE RIGHTS AGREEMENT (this "Agreement") is made as of
August 20, 2002 by and among Evolve Software, Inc., a Delaware corporation (the
"Company"), and the entities listed on the signature pages hereto (the
"Stockholders").
RECITALS
A. The Company and each purchaser of Series B Preferred Stock of the
Company (the "Series B Purchasers") have entered into that certain Series B
Preferred Stock Purchase Agreement dated August 20, 2002 (the "Series B
Purchase Agreement"), pursuant to which the Company has agreed to sell, and
such purchasers have agreed to purchase up to an aggregate of 700,000 shares of
Series B Preferred Stock of the Company (the "Series B Preferred Stock").
B. In order to induce the Series B Purchasers to enter into the Series B
Purchase Agreement, the Company wishes to grant to the Series B Purchasers the
rights set forth in this Agreement.
AGREEMENT
NOW, THEREFORE, the parties hereby agree as follows:
1. Preemptive Rights.
The Company hereby grants to each Stockholder a right (the "Preemptive
Right") to purchase all or any part of its Pro Rata Share of any New Securities
(as hereinafter defined) that the Company may, from time to time, propose to
sell and issue. For purposes of this Section 1, "Pro Rata Share" shall mean the
ratio of (x) the sum of the number of shares of Common Stock of the Company
(the "Common Stock") issued or issuable upon the conversion of all shares of
Series A Preferred Stock of the Company (the "Series A Preferred Stock") and
Series B Preferred Stock of the Company (together with the Series A Preferred
Stock, the "Preferred Stock") held by such Stockholder plus the number of
shares of Common Stock issued or issuable upon conversion of Preferred Stock
issuable or issued upon conversion of outstanding warrants to purchase Series A
Preferred Stock issued to such Stockholder by the Company pursuant to the
Series A Purchase Agreement (as defined below) and held by such Stockholder,
plus the number of shares of Common Stock issuable or issued upon the exercise
of warrants to purchase Common Stock issued to such Stockholder by the Company
pursuant to the Series A Purchase Agreement and held by such Stockholder, to
(y) the sum of the total number of shares of Common Stock then outstanding plus
the total number of shares of Common Stock issuable upon the conversion or
exchange of the total number of shares of Preferred Stock and other securities
convertible into or exchangeable or
-1-
exercisable for Common Stock (whether directly or indirectly) then outstanding.
This Preemptive Right shall be subject to the following provisions:
a. "New Securities" shall mean any capital stock of the Company, whether
or not authorized on the date hereof; provided, however, that "New Securities"
shall not include the following:
(i) shares of capital stock of the Company issuable upon conversion
or exercise of any currently outstanding securities or any New Securities
issued in accordance with this Agreement;
(ii) securities issuable pursuant to the Series B Purchase Agreement
or upon the exercise or conversion of any security issued pursuant to the
Series B Purchase Agreement or the Series A Purchase Agreement dated September
23, 2001 between the Company and certain of the Stockholders (the "Series A
Purchase Agreement");
(iii) securities issued to officers, directors or employees of, or
consultants to, the Company pursuant to a stock grant, option plan or purchase
plan or other stock incentive program, including without limitation sales of
shares to such persons pursuant to restricted stock purchase agreements
approved by the Board of Directors of the Company;
(iv) securities issued as a dividend or distribution on Preferred
Stock or in connection with any stock split, stock dividend or similar
transaction;
(v) securities issued upon exercise or conversion of warrants to
purchase shares of Common Stock issued in connection with (1) equipment lease
financing transactions with institutions regularly engaged in equipment leasing
or (2) bank lending, if such transactions are approved by the Board of
Directors of the Company, and the issuance of such warrants is not principally
for the purpose of raising additional equity capital for the Company; provided
however that the number of shares of New Securities so excluded in any fiscal
year of the Company shall not exceed 0.5% of the number of shares of Common
Stock outstanding and the number of New Securities so excluded in the aggregate
shall not exceed 1.5% of the number of shares of Common Stock outstanding, in
each case determined as of the date of issuance of such New Securities, after
giving effect to the conversion of all outstanding shares of Preferred Stock
and other securities convertible into Common Stock, unless such grants are
approved by a majority of the present and voting directors of the Company
elected by the holders of Preferred Stock;
(vi) securities issued to customers, vendors or joint venture
partners or in connection with other strategic alliances approved by the Board
of Directors which involve the grant of licenses or localization, distribution,
OEM, bundling, manufacturing or resale rights with respect to the Company's
products or technology; provided that the aggregate number of shares of Common
Stock so issued subsequent to the date hereof shall not exceed 2,000,000 shares
(as adjusted for stock splits, stock dividends and similar events);
-2-
(vii) securities issued in a firm-commitment underwritten public
offering pursuant to a registration statement filed under the Securities Act of
1933, as amended, provided that the Company shall have used its best efforts to
make a Pro Rata Share of such securities available to each Stockholder;
(viii) securities issued pursuant to a business combination
transaction or acquisition of technology or other assets of another business;
and
(ix) securities issued by way of dividend or other distribution on
shares excluded from the definition of New Securities by the foregoing clauses
(i), (ii), (iii), (iv), (v), (vi) (vii) and (viii), provided that such issuance
is made (x) pursuant to obligations of the Company established in connection
with the original issuance of such securities or (y) to all holders of the
Company's outstanding capital stock in proportion to the number of shares held.
b. Notice. In the event that the Company proposes to undertake an issuance
of New Securities, it shall give each Stockholder written notice (the "Notice")
of its intention, describing the type of New Securities, the price, and the
material terms and conditions upon which the Company proposes to issue the same
to any person. Such Stockholder shall have fifteen (15) business days after
issuance of such notice to agree to purchase all or any portion of its Pro Rata
Share of such New Securities at the price and upon the terms specified in the
notice (which terms shall be no less favorable than those offered to the third
party purchaser) by giving written notice to the Company and stating therein
the quantity of New Securities to be purchased.
c. Sale by Company. In the event that any New Securities subject to the
Preemptive Right are not purchased by a Stockholder within the period specified
above, the Company shall have one hundred twenty (120) days thereafter to sell
(or enter into an agreement pursuant to which the sale of New Securities that
had been subject to the Preemptive Right shall be closed, if at all, within
sixty (60) days from the date of said agreement) the New Securities with
respect to which the rights of the Stockholders were not exercised at a price
and upon terms and conditions, including manner of payment, no more favorable
to the purchasers thereof than specified in the Notice. In the event the
Company has not sold all offered New Securities within such one hundred twenty
(120) day period (or sold and issued New Securities in accordance with the
foregoing within sixty (60) days from the date of such agreement), the Company
shall not thereafter issue or sell any New Securities without first offering a
portion of such New Securities to the Stockholders in the manner provided
above.
d. Termination. Each Stockholder's rights pursuant to this Section 1 shall
terminate and be without further effect upon such time as such Stockholder
(together with its affiliates) holds less than 10% of the total number of
shares of Common Stock, after giving effect to the conversion of all shares of
Preferred Stock and other securities of the Company convertible into or
exchangeable for Common Stock.
-3-
2. Termination of Rights under Prior Preemptive Rights Agreement. Each
Stockholder hereby agrees that this Agreement supersedes the Preemptive Rights
Agreement dated October 9, 2001 by and among the Company and certain holders of
Series A Preferred Stock of the Company (the "Prior Agreement") and each
Stockholder hereby waives any and all of rights held by such Stockholder
pursuant to the Prior Agreement.
3. Notices. Any notice required or permitted to be given to a party
pursuant to the provisions of this Agreement shall be in writing and shall be
effective upon personal delivery or on the first business day after deposit
with a guaranteed overnight messenger service or on the fifth business day
after deposit in the U.S. mail, registered or certified, with postage prepaid
and properly addressed to the party to be notified or, if by facsimile, on the
first business day after receipt of the appropriate confirmation of receipt.
Mailed notices shall be addressed, and sent, (i) if to the Company, at 0000
00xx Xxxxxx, Xxxxx 000, Xxxxxxxxxx, Xxxxxxxxxx 00000, Attention: General
Counsel and (ii) if to a Purchaser, at such Purchaser's address as reflected on
the signature pages hereto.
4. Severability. If for any reason any provision of this Agreement shall
be determined to be invalid or inoperative, the validity and effect of the
other provisions hereof shall not be effected thereby, provided that not such
severability shall be effective if it causes a material detriment to any party.
5. Applicable Law. This Agreement shall be governed by and construed in
accordance with the laws of the State of Delaware applicable to contracts
between Delaware residents entered into and to be performed entirely within the
State of Delaware.
6. Amendment. Any provision of this Agreement may be amended, waived or
modified only upon the written consent of the (i) Company and (ii) the party to
be charged with such amendment, waiver or modification.
7. Counterparts. This Agreement may be executed in any number of
counterparts, each of which may be executed by less than all of the parties,
each of which shall be enforceable against the parties actually executing such
parts, and all of which together shall constitute one instrument.
8. Entire Agreement. This Agreement constitutes the full and entire
understanding and agreement between the parties regarding the subject matter
hereof.
-4-
IN WITNESS WHEREOF, the undersigned or each of their respective duly
authorized officers or representatives have executed this Agreement effective
upon the date set forth above.
"COMPANY"
EVOLVE SOFTWARE, INC.
By:
----------------------------------------
Name:
--------------------------------------
Title:
-------------------------------------
"PURCHASER"
Signature:
---------------------------------
Name of Signer:
----------------------------
Name of Purchaser:
-------------------------
Address:
-----------------------------------
SIGNATURE PAGE TO SERIES B PREEMPTIVE RIGHTS AGREEMENT
